Sysmex Europe SE and SMD GmbH are pleased to announce the expansion of the distribution agreement of geneLEAD® VIII and SMD lead kits which provide a reliable and flexible molecular solution for laboratories in 20 additional markets.
The new regions are: Central & Western Europe:
Belgium, the Netherlands, the United Kingdom and Poland.
Iberian Peninsula & Atlantic Territories:
Spain, Portugal, Andorra, Gibraltar and French Guiana.
Southern Europe & Mediterranean:
Monaco, Italy (including San Marino and Vatican City), Greece, Cyprus (EU) and Malta.
Western Balkans:
Albania, Bosnia and Herzegovina, Kosovo, Montenegro, North Macedonia and Serbia.
Maghreb:
Algeria, Morocco, Tunisia and Mauritania.
Distribution across these markets will be handled through Sysmex affiliates and local distribution partners to not only ensure reliable product availability but also responsive service consistent with the high standards previously established in the initial launch countries. The expansion brings the total number of markets covered by the agreement for over 30 countries across Europe, North Africa and associated territories.
Further information on the geneLEAD® VIII platform and SMD lead kits, including the original partnership announcement, is available at www.sysmex-europe.com and https://www.sm-dx.com/en.
About SMD GmbH
SMD distributes cutting-edge solutions for molecular diagnostics, actively contributing to medical progress. The company unites a team of seasoned experts who have been active in the field for many years to channel their extensive expertise into the development of innovative technology – where the hardware components are produced in Japan and the reagents in Germany. SMD is a German company based in Göppingen operating worldwide to provide high-quality service and products to its partners.
For more information, visit https://www.sm-dx.com/en
About Sysmex Europe SE
Sysmex supports healthcare professionals and patients around the world with a broad range of medical diagnostics products and solutions in a variety of fields. With over 50 years of experience in in vitro diagnostics, we are continuously developing our product and service portfolio to cover the entire patient pathway of care. Sysmex Europe SE, located near Hamburg, Germany, is a subsidiary of the Sysmex Corporation, based in Kobe, Japan. From our Hamburg offices, we serve our affiliates, distributors and customers throughout Europe, the Middle East and Africa (EMEA).
For more information, visit www.sysmex-europe.com
